Welcome to the e-CCO Library!

P712: Tofacitinib efficacy in patients with moderate to severe ulcerative colitis: Subgroup analyses of OCTAVE Induction 1 and 2 and OCTAVE Sustain by 5-aminosalicylates use
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. Hanauer1, D. T. Rubin2, P. Gionchetti3, C. Su4, D. A. Woodworth4, D. Quirk4, L. Salese4, W. Wang4, A. Marren4, N. Lawendy4, R. Panaccione*5

Created: Friday, 22 February 2019, 9:41 AM
P713 Effects of vedolizumab on health-related quality of life, work productivity and patient concerns in patients with ulcerative colitis and Crohn’s disease in the UK and Ireland: OCTAVO cohort 2
Year: 2020
Source:

ECCO'20 Vienna

Authors:

G. Parkes1, A. Akbar2, I. Beales3, M. Buckley4, T. Creed5, S. Din6, A. Fraser5, N. Plevris7, S. Meadowcroft8, G. Owen9, N. Heggs8, OCTAVO

Created: Thursday, 30 January 2020, 10:12 AM
P713: Gut microbiota alterations after bowel preparation amongst inflammatory bowel disease patients
Year: 2022
Source: ECCO'22
Authors: Rutka, M.(1);Szántó, K.(1);Bacsur, P.(1);Resál, T.(1);Jójárt, B.(2);Bálint, A.(1);Ari, E.(3);Kintses, B.(4);Fehér, T.(4);Asbóth, A.(5);Pigniczki, D.(1);Bor, R.(1);Fábián, A.(1);Farkas, K.(1);Maléth, J.(2);Szepes, Z.(1);Molnár, T.(1);
Created: Friday, 11 February 2022, 3:56 PM
P713: Home-based vedolizumab infusions: A suitable alternative to routine hospital infusions
Year: 2018
Source: ECCO '18 Vienna
Authors:

N. Peek-Kuijt1*, J. Nieuwstraten1, L. van Ginkel2, J. Maljaars1, A. van der Meulen- de Jong1

Created: Thursday, 21 February 2019, 9:14 AM
P713: Long-term efficacy of endoscopic balloon dilatation using single-balloon enteroscopy in patients with Crohn’s disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

K. Takahashi*1, S. Bamba2, Y. Morita1, A. Nishida1, M. Sasaki2, T. Tsujikawa3, A. Andoh1

Created: Friday, 22 February 2019, 9:41 AM
P713: Possible explanations of the marked differences in the incidence of microscopic colitis between Denmark and Sweden
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Davidson S.*1, Munck L.2, Vigren L.3, Engel P.4, Sjöberg K.3

Created: Wednesday, 20 February 2019, 10:36 AM
P713: Proactive therapeutic infliximab monitoring during induction phase in inflammatory bowel disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Gonzalez Vivo, M.(1,2)*;Carballo Martinez, N.(2,3);Padulles Zamora, N.(4);Colominas Gonzalez, E.(2,3);Murciano Gonzalo, F.(1);Abril Rodriguez, L.(1);Marquez-Mosquera, L.(1,2);
Created: Friday, 14 July 2023, 11:12 AM
P714 Real-world effectiveness of vedolizumab in ulcerative colitis: Week 52 results from the Swedish multi-centre, prospective, observational SVEAH UC study
Year: 2020
Source:

ECCO'20 Vienna

Authors:

C. ERIKSSON1, S. Rundquist1, V. Lykiardopoulos2, R. Udumyan3, P. Karlén4, O. Grip5, C. Söderman6, S. Almer7, E. Hertervig8, J. Gunnarsson9, C. Malmgren10, J. Delin11, H. Strid12, M. Sjöberg13, D. Öberg14, D. Bergemalm1, H. Hjortswang2, J. Halfvarson1

Created: Thursday, 30 January 2020, 10:12 AM
P714: Comparison of intestinal microbiota profiles of faecal samples, rectal swabs and mucosal biopsies in patients with Inflammatory Bowel Disease. A multicentre, observational study.
Year: 2022
Source: ECCO'22
Authors: Van Rossen, T.(1);van den Hoek, K.(2);Budding, A.(3);van Bodegraven, A.(4);
Created: Friday, 11 February 2022, 3:56 PM
P714: Efficacy and safety of infliximab retreatment in luminal Crohn’s disease: a multi-centre, prospective, observational cohort (REGAIN) study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

G. Boschetti*1, B. Pariente2, D. Laharie3, X. Roblin4, C. Gilletta5, A. Aubourg6, A. Bourreille7, C. Zallot8, X. Hebuterne9, A. Buisson10, J-C. Grimaud11, Y. Bouhnik12, M. Allez13, R. Altwegg14, S. Viennot15, L. Vuitton16, F. Carbonnel17, M. Nachury2, S. Paul18, J. Lambert19, L. Peyrin-Biroulet8, Getaid1

Created: Friday, 22 February 2019, 9:41 AM
P714: Mucosal healing in CD with vedolizumab versus other biologics: endoscopic outcomes during long-term routine care in a multinational observational study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Siegel, C.(1)*;Sebastian, S.(2);Siegmund, B.(3);Zhou, J.(4);Jones, S.(5);Adsul, S.(4);Louis, E.(6);
Created: Friday, 14 July 2023, 11:12 AM
P714: Vedolizumab, an adequate option in medically refractory and thiopurine-intolerant inflammatory bowel disease patients
Year: 2018
Source: ECCO '18 Vienna
Authors:

M. Iborra1*, N. Maroto2, P. Navarro-Cortes3, B. Beltran1, M. Boscá-Watts3, I. Ferrer2, N. Garcia-Morales1, E. Sáez-González1, J. Hinojosa2, M. Minguez3, P. Nos1

Created: Thursday, 21 February 2019, 9:14 AM
P714: Vitamin D deficiency in inflammatory bowel disease: prevalence and relation to disease activity in a cohort of patients of a Mediterranean country
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Branco J.C., Cardoso M., Anapaz V., Lourenço L., Oliveira A.M., Rodrigues C.G., Santos L., Reis J.

Created: Wednesday, 20 February 2019, 10:36 AM
P715 The prevalence of chronic musculoskeletal pain in patients with ulcerative colitis in comparison to control subjects: A cross-sectional study
Year: 2020
Source:

ECCO'20 Vienna

Authors:

N. Pettersson1, F. Kragsbjerg1, A. Hamrin2, H. Forsblad-D′elia3, P. Karling1

Created: Thursday, 30 January 2020, 10:12 AM
P715: Achievement and maintenance of endoscopic, histologic, and combined outcomes after extended induction in Week 10 nonresponders of ozanimod: 2-year interim analysis of the True North open-label extension study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Vermeire, S.(1)*;Colombel, J.F.(2);Rubin, D.T.(3);Ghosh, S.(4);Jain, A.(5);Lawlor, G.(5);Osterman, M.T.(5);Wu, H.(5);Canavan, J.B.(5);Chiorean, M.V.(6);
Created: Friday, 14 July 2023, 11:12 AM
P715: Opioid use in patients with inflammatory bowel disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

X. Lin, J. Lofland, L. Zhang, K. Lee, S. Sloan*, L. Chamaa, C. Marano, S. Plevy

Created: Thursday, 21 February 2019, 9:14 AM
P715: Real-world tofacitinib effectiveness and safety in patients with refractory ulcerative colitis
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

L. Lair-Mehiri*1, C. Stefanescu1, T. Vaysse2, D. Laharie3, X. Roblin4, I. Rosa5, X. Treton1, V. Abitbol6, A. Amiot7, G. Bouguen8, N. Dib9, M. Fumery10, B. Pariente11, F. Carbonnel2, L. Peryn-Biroulet12, M. Simon13, S. Viennot14, Y. Bouhnik1

Created: Friday, 22 February 2019, 9:41 AM
P715: Trends in emergency department visits and hospitalization rates for inflammatory bowel disease: results from a single-center in 2004, 2009 and 2014
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Huh G.*1, Yoon H.2, Choi Y.J.2, Park Y.S.2, Kim N.1,2, Lee D.H.1,2

Created: Wednesday, 20 February 2019, 10:36 AM
P716 Clinical significance of residual non-rectal inflammation in ulcerative colitis patients with clinical remission
Year: 2020
Source:

ECCO'20 Vienna

Authors:

J. Shin, G. Seong, J.H. Song, S.M. Kong, T.J. Kim, E.R. Kim, S.N. Hong, D.K. Chang, Y.H. Kim

Created: Thursday, 30 January 2020, 10:12 AM